Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong ...
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients ...
SeaStar Medical Holding ( ($ICU) ) has provided an announcement. On September 24, 2025, SeaStar Medical announced that the independent Data Safety ...
Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- ...
SeaStar Medical Holding Corporation (NASDAQ:ICU) shares are trading higher on Thursday, on continued strength after the company received FDA Breakthrough Device Designation for its cell-directed ...
SeaStar Medical (NASDAQ:ICU) said it has received an Approvable Letter from the FDA for its Selective Cytopheretic Device Pediatric, or SCD-PED, for use in children with acute kidney injury and sepsis ...
DENVER, COLORADO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary ...
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation ...
TipRanks on MSN
Why Is SeaStar Medical Stock (ICU) Down 45% Today?
Turning to Wall Street, the analysts’ consensus rating for SeaStar Medical is Moderate Buy, based on a single Buy rating over ...
Background Sudden cardiac death (SCD) is a common cause of cardiovascular mortality, often triggered by ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback